Connection

Albert Finn to Drug Administration Schedule

Back to Details
This is a "connection" page, showing publications Albert Finn has written about Drug Administration Schedule.
Albert Finn
Connection Strength
0.012
Drug Administration Schedule
  1. Efficacy and safety of desloratadine 5 mg once daily in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial. J Am Acad Dermatol. 2003 Apr; 48(4):535-41.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.